Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% in high-risk adults, as the drugmaker joined the race for an easy-to-use medication to treat the coronavirus.
Related posts
-
Willow Creek worshipers gather on Christmas Eve
Willow Creek Community Church members came together on Tuesday to experience the hope and peace of... -
Santa, firefighters bring Christmas cheer to Elgin family
Santa Claus and a team of Elgin firefighters brought gifts to an Elgin family on Tuesday. -
Naperville woman dies after crash
A 38-year-old woman was killed Monday night when her SUV left the road and struck two...